{"title":"Everest Medicines Announces China NMPA Approval of VELSIPITYÂ® for Adults with Moderately to Severely Active Ulcerative Colitis","path":"/2026/02/06/everest-medicines-announces-china-nmpa-approval-of-velsipity-for-adults-with-moderately-to-severely-active-ulcerative-colitis/","site":"https://laotiantimes.com","atUri":"at://did:plc:svcthvzunxmjidtlw23zva6n/site.standard.document/3me6f4os5qca2","publishedAt":"2026-02-06T05:10:00Z","tags":"Cision PR Newswire"}